The North America Cell Therapy Market would witness market growth of 24.8% CAGR during the forecast period (2020-2026). Cell therapy technologies have a vital role to play in the domain of medicine and cell therapy is bound to become an aspect of medical practice.
Cell therapy technologies have common functionality as cancer vaccines, gene therapy, tissue engineering, drug delivery, and regenerative medicine. Procedures of delivery of cell therapy products vary from injections to surgical implantation by utilizing some specific equipment. Cell therapy finds potential applications in various kinds of disorders, and cancer & nervous systems are the major ones. Other applications involve diabetes mellitus, genetic disorders, diseases of bones and joints, cardiac disorders (myocardial infarction and heart failure), and wounds of the skin & soft tissues.
A surge in adoption of human cells for cell therapy research, technological developments in the domain of cell therapy, and rise in occurrences of diseases like cancer and cardiac abnormalities are the major aspects that boost the development of the market. Moreover, the formulation of strict government norms with respect to the utilization of cell therapy would hamper the development of the cell therapy market. However, a rise in the number of norms that aim to support stem cell therapy and a surge in investments for R&D activities in emerging countries would present new growth avenues for the market in the next few years.
Moreover, the domain of regenerative medicine is going through various developments, further anticipated to provide effective treatment solutions for chronic diseases. Various companies in the developing regions, like Canada, are working hard to explore the undiscovered potential of the market for cell therapy. For example, RepliCel is investing heavily in various projects of regenerative medicine. For example, in February 2021, the company made an announcement regarding the plans for the commercialization and clinical testing of 3 extra technologies in Japan. These involve 2 cell-based therapies – one for skin rejuvenation and the other for tendon regeneration.
The US market dominated the North America Allogeneic Market by Country 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 29.7% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 28.7% during (2020 - 2026).
The Malignancies market dominated the Canada Cell Therapy Market by Therapeutic Area 2019, thereby, achieving a market value of $767.2 million by 2026. The Autoimmune Disorders market is showcasing a CAGR of 29% during (2020 - 2026). Additionally, The Musculoskeletal Disorders market is estimated to grow at a CAGR of 28.6% during (2020 - 2026).
Based on Therapy Type, the market is segmented into Autologous and Allogeneic. Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Cell Therapy Market in North America is expected to register a CAGR of 24.8% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
By Therapeutic Area
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
By End User
- Academic & Research Institutes
- Hospitals & Clinics
By Cell Type
- Stem Cell
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Non-Stem Cell
- Bone Marrow
- Blood
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Fujifilm Holdings Corporation
- Smith & Nephew PLC
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Medipost Co., Ltd.
- Stemedica Cell Technologies, Inc.
- NuVasive, Inc.
- Avantor, Inc.
- Vericel Corporation
- Pharmicell Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell Therapy Market, by Therapy Type
1.4.2 North America Cell Therapy Market, by Therapeutic Area
1.4.3 North America Cell Therapy Market, by End User
1.4.4 North America Cell Therapy Market, by Cell Type
1.4.5 North America Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. North America Cell Therapy Market by Therapy Type
4.1 North America Autologous Market by Country
4.2 North America Allogeneic Market by Country
Chapter 5. North America Cell Therapy Market by Therapeutic Area
5.1 North America Malignancies Market by Country
5.2 North America Autoimmune Disorders Market by Country
5.3 North America Musculoskeletal Disorders Market by Country
5.4 North America Dermatology Market by Country
5.5 North America Other Therapeutic Area Market by Country
Chapter 6. North America Cell Therapy Market by Therapy Type
6.1 North America Academic & Research Institutes Market by Country
6.2 North America Hospitals & Clinics Market by Country
Chapter 7. North America Cell Therapy Market by Cell Type
7.1 North America Stem Cell Market by Country
7.2 North America Umbilical Cord-Derived Cell Market by Country
7.3 North America Adipose-Derived Stem Cell Market by Country
7.4 North America Non-Stem Cell Market by Country
7.5 North America Bone Marrow Cell Market by Country
7.6 North America Blood Cell Market by Country
7.7 North America Others Cell Market by Country
Chapter 8. North America Cell Therapy Market by Country
8.1 US Cell Therapy Market
8.1.1 US Cell Therapy Market by Therapy Type
8.1.2 US Cell Therapy Market by Therapeutic Area
8.1.3 US Cell Therapy Market by End User
8.1.4 US Cell Therapy Market by Cell Type
8.2 Canada Cell Therapy Market
8.2.1 Canada Cell Therapy Market by Therapy Type
8.2.2 Canada Cell Therapy Market by Therapeutic Area
8.2.3 Canada Cell Therapy Market by End User
8.2.4 Canada Cell Therapy Market by Cell Type
8.3 Mexico Cell Therapy Market
8.3.1 Mexico Cell Therapy Market by Therapy Type
8.3.2 Mexico Cell Therapy Market by Therapeutic Area
8.3.3 Mexico Cell Therapy Market by End User
8.3.4 Mexico Cell Therapy Market by Cell Type
8.4 Rest of North America Cell Therapy Market
8.4.1 Rest of North America Cell Therapy Market by Therapy Type
8.4.2 Rest of North America Cell Therapy Market by Therapeutic Area
8.4.3 Rest of North America Cell Therapy Market by End User
8.4.4 Rest of North America Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Cell Therapy Market, 2016 - 2019, USD Million
TABLE 2 North America Cell Therapy Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell Therapy Market
TABLE 4 Product Launches And Product Expansions– Cell Therapy Market
TABLE 5 Geographical Expansions– Cell Therapy Market
TABLE 6 Approvals & Trials– Cell Therapy Market
TABLE 7 Acquisition and Mergers– Cell Therapy Market
TABLE 8 North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 9 North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 10 North America Autologous Market by Country, 2016 - 2019, USD Million
TABLE 11 North America Autologous Market by Country, 2020 - 2026, USD Million
TABLE 12 North America Allogeneic Market by Country, 2016 - 2019, USD Million
TABLE 13 North America Allogeneic Market by Country, 2020 - 2026, USD Million
TABLE 14 North America Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 15 North America Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 16 North America Malignancies Market by Country, 2016 - 2019, USD Million
TABLE 17 North America Malignancies Market by Country, 2020 - 2026, USD Million
TABLE 18 North America Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
TABLE 19 North America Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
TABLE 20 North America Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
TABLE 21 North America Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
TABLE 22 North America Dermatology Market by Country, 2016 - 2019, USD Million
TABLE 23 North America Dermatology Market by Country, 2020 - 2026, USD Million
TABLE 24 North America Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
TABLE 25 North America Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
TABLE 26 North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 27 North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 28 North America Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
TABLE 29 North America Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
TABLE 30 North America Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
TABLE 31 North America Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
TABLE 32 North America Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 33 North America Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 34 North America Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 35 North America Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 36 North America Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
TABLE 37 North America Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
TABLE 38 North America Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 39 North America Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 40 North America Non-Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 41 North America Non-Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 42 North America Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
TABLE 43 North America Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
TABLE 44 North America Blood Cell Market by Country, 2016 - 2019, USD Million
TABLE 45 North America Blood Cell Market by Country, 2020 - 2026, USD Million
TABLE 46 North America Others Cell Market by Country, 2016 - 2019, USD Million
TABLE 47 North America Others Cell Market by Country, 2020 - 2026, USD Million
TABLE 48 North America Cell Therapy Market by Country, 2016 - 2019, USD Million
TABLE 49 North America Cell Therapy Market by Country, 2020 - 2026, USD Million
TABLE 50 US Cell Therapy Market, 2016 - 2019, USD Million
TABLE 51 US Cell Therapy Market, 2020 - 2026, USD Million
TABLE 52 US Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 53 US Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 54 US Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 55 US Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 56 US Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 57 US Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 58 US Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 59 US Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 60 Canada Cell Therapy Market, 2016 - 2019, USD Million
TABLE 61 Canada Cell Therapy Market, 2020 - 2026, USD Million
TABLE 62 Canada Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 63 Canada Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 64 Canada Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 65 Canada Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 66 Canada Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 67 Canada Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 68 Canada Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 69 Canada Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 70 Mexico Cell Therapy Market, 2016 - 2019, USD Million
TABLE 71 Mexico Cell Therapy Market, 2020 - 2026, USD Million
TABLE 72 Mexico Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 73 Mexico Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 74 Mexico Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 75 Mexico Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 76 Mexico Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 77 Mexico Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 78 Mexico Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 79 Mexico Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 80 Rest of North America Cell Therapy Market, 2016 - 2019, USD Million
TABLE 81 Rest of North America Cell Therapy Market, 2020 - 2026, USD Million
TABLE 82 Rest of North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 83 Rest of North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 84 Rest of North America Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 85 Rest of North America Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 86 Rest of North America Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 87 Rest of North America Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 88 Rest of North America Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 89 Rest of North America Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 90 Key Information – Fujifilm Holdings Corporation
TABLE 91 key Information – Smith & Nephew PLC
TABLE 92 key information – Kolon TissueGene, Inc.
TABLE 93 Key Information – JCR Pharmaceuticals Co., Ltd.
TABLE 94 Key Information – Medipost Co., Ltd.
TABLE 95 key Information – Stemedica Cell Technologies, Inc.
TABLE 96 Key Information – NuVasive, Inc.
TABLE 97 key information – Avantor, Inc.
TABLE 98 Key Information – Vericel Corporation
TABLE 99 Key Information – Pharmicell Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 5 Recent strategies and developments: Smith & Nephew PLC
FIG 6 Recent strategies and developments: JCR Pharmaceuticals Co., Ltd.
FIG 7 Recent strategies and developments: Avantor, Inc.
FIG 8 Recent strategies and developments: Vericel Corporation